C12Y304/14005 - CPC Classification Index

#1

20260062705

2026-03-05

TREATMENT FOR OVARIAN CANCER WITH OLIGONUCLEOTIDES TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA

#2

20260049160

2026-02-19

TETRAVALENT MULTISPECIFIC ANTIBODIES

#3

20250313879

2025-10-09

Fluorescent Probe for Detecting Peptide Bond Hydrolase

#4

20240408185

2024-12-12

DPP-4 INHIBITOR AND PRODUCTION METHOD THEREFOR

#5

20240123097

2024-04-18

Dual-Mode Pharmaceutical Composition for Peptide-Specific Targeted Positron Emission Tomography and Boron Neutron Capture Therapy and the Use Thereof

#6

20230416716

2023-12-28

DIPEPTIDYLPEPTIDASE AND LEUCINE AMINOPEPTIDASE POLYPEPTIDE VARIANTS

#7

20230405150

2023-12-21

VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES

#8

20230212589

2023-07-06

MULTIPLE RAPID DETECTION KITS AND METHODS FOR VARIOUS VIRUSES

#9

20220315554

2022-10-06

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

#10

20220305061

2022-09-29

COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS

#11

20220049020

2022-02-17

TETRAVALENT MULTISPECIFIC ANTIBODIES

#12

20220023398

2022-01-27

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE

#13

20210246431

2021-08-12

Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor

#14

20210235674

2021-08-05

Humanized dipeptidyl-peptidase IV (DPP4) animals

#15

20200121740

2020-04-23

PHARMACEUTICAL COMPOSITIONS CONTAINING PEDIOCOCCUS AND METHODS FOR REDUCING THE SYMPTOMS OF GASTROENTEROLOGICAL SYNDROMES

#16

20200071411

2020-03-05

Bispecific antibodies specific for OX40

#17

20190374623

2019-12-12

TREATMENTS FOR HEART FAILURE AND CARDIAC ISCHAEMIC REPERFUSION INJURY

#18

20190134165

2019-05-09

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE

#19

20190124896

2019-05-02

Humanized dipeptidyl-peptidase IV (DPP4) animals

#20

20180117130

2018-05-03

Enzyme formulation for reducing histamine intolerance

#21

20180022822

2018-01-25

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF

#22

20180009907

2018-01-11

NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES

#23

20170369592

2017-12-28

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOF

#24

20170290894

2017-10-12

Compositions and methods for treating thyroid disease

#25

20170274056

2017-09-28

Enzyme formulation for reducing histamine intolerance

#26

20170145116

2017-05-25

TETRAVALENT MULTISPECIFIC ANTIBODIES

#27

20170114141

2017-04-27

Bispecific antibodies specific for OX40

#28

20170112107

2017-04-27

Humanized dipeptidyl-peptidase IV (DPP4) animals

#29

20160363591

2016-12-15

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG

#30

20160339086

2016-11-24

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE

#31

20160317627

2016-11-03

PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEASES AND METHODS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES

#32

20160296612

2016-10-13

Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigens

#33

20160206732

2016-07-21

EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF

#34

20160007579

2016-01-14

Humanized dipeptidyl peptidase IV (DPP4) animals

#35

20150351372

2015-12-10

Humanized dipeptidyl peptidase IV (DPP4) animals

#36

20150329646

2015-11-19

NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES

#37

20150275183

2015-10-01

Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor

#38

20150266922

2015-09-24

DPP8 and DPP9 peptide inhibitors

#39

20150118290

2015-04-30

METHOD FOR REDUCING ESTABLISHED METASTATIC TUMOR BY PHARMACEUTICAL COMPOSITION CONTAINING POLYPEPTIDE

#40

20150065693

2015-03-05

Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor

#41

20140309401

2014-10-16

DPP-4 inhibitor

#42

20140142036

2014-05-22

Dipeptidyl peptidase-4 inhibitor

#43

20130039897

2013-02-14

COMPOSITIONS AND METHODS FOR REGULATING NEUTROPHIL MOVEMENT AND NEUTROPHIL NUMBERS IN A BODY REGION

#44

20120315263

2012-12-13

Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases

#45

20120189611

2012-07-26

DIPEPTIDYL PEPTIDASE-4 INHIBITOR

#46

20110293724

2011-12-01

Enzyme treatment of foodstuffs for celiac sprue

#47

20110183919

2011-07-28

Dipeptidyl peptidase IV (DP-IV) compounds

#48

20100233318

2010-09-16

PROCESS FOR THE HYDROLYSIS OF MILK PROTEINS

#49

20090304670

2009-12-10

FOOD PRODUCT COMPRISING A PROLINE SPECIFIC PROTEASE, THE PREPARATION THEREOF AND ITS USE FOR DEGRADING TOXIC OR ALLERGENIC GLUTEN PEPTIDES

#50

20090280555

2009-11-12

ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE

#51

20080213822

2008-09-04

Methods for diagnosing celiac sprue and reagents useful therein

#52

20080213427

2008-09-04

Enzyme treatment of foodstuffs for celiac sprue

#53

20080213245

2008-09-04

Enzyme treatment of foodstuffs for Celiac Sprue

#54

20080145356

2008-06-19

Enzyme treatment of foodstuffs for celiac sprue

#55

20070092501

2007-04-26

Compositions and methods relating to reduction of symptoms of autism

#56

20050260732

2005-11-24

Three-dimensional structure of dipeptidyl peptidase IV